Ethan Kowalski
Performance Science Writer
Ethan writes the training, recovery, and performance beat. A former strength coach, he focuses on what recovery research means for people who actually train hard.
Survodutide Research Overview: What Studies Show About This Dual Glucagon GLP 1 Receptor Agonist
A look at what published trials show about survodutide, a dual glucagon and GLP 1 receptor agonist studied for weight loss and liver disease.
Tirzepatide Study Looks at Weight Regain Over 3 Years
A new analysis examines weight nadirs and regain during 3 years of tirzepatide treatment in people with obesity and prediabetes.
FDA Warns Empower Pharmacy Over Compounded Tirzepatide and Semaglutide Products
FDA warning letter cites Empower Pharmacy for compounding tirzepatide and semaglutide products as copies of approved drugs.
Adipotide Research Overview: What Studies Show About This Fat Targeting Peptide
Adipotide shrank fat tissue in animal studies by cutting its blood supply, but kidney safety concerns have stalled human research.
FDA Expands Approval for Sevabertinib in Lung Cancer
FDA granted accelerated approval to sevabertinib for HER2 mutated non small cell lung cancer patients with no prior treatment.
TB-500: What the Research Actually Shows
TB-500 is an investigational peptide studied mostly in animals for wound healing, blood vessel growth, and cardiac repair.
Peptides for Recovery and Healing: The Complete Research Guide
A coach's look at the recovery peptide research: what BPC-157, TB-500, GHK-Cu, and their cousins actually show, and where the evidence stops.